Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Modeling the course and outcomes of MS is statistical twaddle-No.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.
Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
IV immunoglobulin confounds JC virus antibody serostatus determination.
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Atypical presentation of multiple sclerosis.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
["Time is brain" in relapsing remitting multiple sclerosis : Current treatment concepts in immunotherapy].
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
Caregiver burden in multiple sclerosis: A structured review of the instruments.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Involvement of Notch1 inhibition in serum-stimulated glia and oligodendrocyte differentiation from human mesenchymal stem cells.
Therapeutic Advances in Pediatric Multiple Sclerosis.
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Disclosing a misdiagnosis of multiple sclerosis: do no harm?
MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
Pages
« first
‹ previous
…
560
561
562
563
564
565
566
567
568
…
next ›
last »